Huons Co., Ltd. (KOSDAQ:243070)

South Korea · Delayed Price · Currency is KRW

17,010

-60 (-0.35%)

Nov 4, 2026, 3:30 PM KST

Market Cap	198.20B -41.7%
Revenue (ttm)	607.75B +2.1%
Net Income	18.86B -46.1%
EPS	1,618.97 -44.3%
Shares Out	11.65M
PE Ratio	10.51
Forward PE	n/a
Dividend	920.00 (5.41%)
Ex-Dividend Date	Aug 28, 2026

Volume	37,422
Open	17,090
Previous Close	17,070
Day's Range	16,520 - 17,090
52-Week Range	16,520 - 41,500
Beta	0.24
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1965

Employees 1,149

Stock Exchange KOSDAQ

Ticker Symbol 243070

Full Company Profile

Financial Performance

In 2025, Huons's revenue was 620.77 billion, an increase of 5.17% compared to the previous year's 590.23 billion. Earnings were 42.66 billion, an increase of 44.84%.

Financial Statements